Login / Signup

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series.

Francesco MenzellaMarco BonaviaMatteo BoniniMaria D'AmatoSalvatore LombardoNicola MurgiaVincenzo PatellaMassimo TriggianiGirolamo Pelaia
Published in: Journal of asthma and allergy (2021)
Our findings further support the efficacy and safety of benralizumab observed in randomized clinical trials, providing even better results for lung function improvement.
Keyphrases
  • lung function
  • chronic obstructive pulmonary disease
  • cystic fibrosis
  • air pollution
  • early onset
  • chronic rhinosinusitis
  • clinical trial
  • double blind